Table 4.

Analysis of survival endpoints (EFS, PFS, CSS, and OS) according to the MALT-IPI risk group in the testing set from the IELSG-19 clinical trial database: risk estimate in Cox models with the low-risk group as the reference group

Risk GroupNEFSPFSCSSOS
HR (95% CI)HR (95% CI)HR (95% CI)HR (95% CI)
Low 167 
Intermediate 165 1.5 (1.1-2.1) 1.7 (1.2-2.5) 5.3 (0.6-45.6) 2.4 (1.05-5.5) 
High 68 3.3 (2.3-4.8) 3.9 (2.6-5.9) 41.5 (5.4-319.7) 13.7 (6.3-29.9) 
Risk GroupNEFSPFSCSSOS
HR (95% CI)HR (95% CI)HR (95% CI)HR (95% CI)
Low 167 
Intermediate 165 1.5 (1.1-2.1) 1.7 (1.2-2.5) 5.3 (0.6-45.6) 2.4 (1.05-5.5) 
High 68 3.3 (2.3-4.8) 3.9 (2.6-5.9) 41.5 (5.4-319.7) 13.7 (6.3-29.9) 
Close Modal

or Create an Account

Close Modal
Close Modal